Integral Diagnostics Ltd · ASX:IDX
Integral Diagnostics — Shareholder Meeting (November 2019)
22 slides from Integral Diagnostics's shareholder meeting presentation, Nov 19, 2019
Slide 1: Integral Diagnostics 2019 AGM
Integral Diagnostics Good Medicine is Good Business For personal use only 2019 AGM Dr. Ian Kadish (MD & CEO) 19 November 2019 0
Slide 2: Presenter: Dr. Ian Kadish
Presenter For personal use only Dr. Ian Kadish Managing Director and Chief Executive Officer • Joined Integral Diagnostics in May 2017 • Has held roles including CSC Healthcare and McKinsey and Company in New York City; and Netcare, a major hospital group in South Africa and the United Kingdom where
Slide 3: IDX - About us
For personal use only IDX - About us Confidential / Draft 2
Slide 4: Integral Diagnostics is a leading Diagnostic Imaging provider in Australia and NZ
Integral Diagnostics (IDX) is a leading Diagnostic Imaging provider in Australia and NZ Concentrated presence in high growth markets – Gold Coast, Sunshine Coast, Western Victoria, Southwest Western For personal use only Australia and South Auckland Leading provider in each geography we serve:
Slide 5: IDX – Our Vision, Culture and Strategy
For personal use only IDX – Our Vision, Culture and Strategy Confidential / Draft 4
Slide 6: IDX Vision, Purpose, Values and Pillars
IDX Vision, Purpose, Values and Pillars For personal use only Vision The leading diagnostic imaging provider, trusted by referrers, preferred by patients Purpose Diagnostic Excellence – Provide better insights into the health of our patients Medical Patients First Everyone Counts Create Value Embrac
Slide 7: Strategy: grow existing business and pursue acquisitions
Strategy is to 1. grow the existing business and margin and 2. progress strategically aligned, earnings accretive acquisitions that demonstrate strong clinical and cultural fit For personal use only Strategy 1 Grow existing business and margin 2 Strategic acquisitions Drive organic Drivers of growth
Slide 8: IDX now operates in five key markets
IDX now operates in five key markets Total IDX For personal use only Geographic Western Victoria New Zealand Queensland Queensland Market Australia Ballarat, Sunshine Coast, Geelong, South West Gold Coast, Rockhampton, Core markets Warrnambool, Western Auckland Toowoomba Gladstone and North and West
Slide 9: IDX Performance
For personal use only IDX Performance Confidential / Draft 8
Slide 10: FY19 IDX highlights
FY19 IDX highlights • Delivered solid growth in FY19 41% in operating NPAT For personal use only 30% in operating EPS (FY18: 20% organic growth) 23% in operating revenue; 7.4% same-store revenue growth 39% in Statutory NPAT • Successfully integrated acquisitions in Auckland and Geelong with
Slide 11: FY19 highlights continued
FY19 highlights continued For personal use only • Revised radiologist remuneration and incentive structure Introduced Radiologist Share Plans to broaden radiologist shareholder base Developed incentive plan for SCR and Lake businesses to drive revenue growth and productivity Agreed full escrow
Slide 12: IDX is growing well on all key financial metrics
IDX is growing well on all key financial metrics Revenue ($m) Operating EBITDA ($m) 232.4 53 For personal use only 179.7 189.4 38.1 33.5 FY17 FY18 FY19 FY17 FY18 FY19 Operating NPAT ($m) Earnings Per Share Dividends Per Share 25.6 18.2 15.1 5c 3c 4c 16.3c 4¢ 12.5c 10.4c 4¢ 4c 4c 5c 3¢ FY17 FY18 FY19
Slide 13: Share price performance since IPO
Share price performance since IPO $4.00 11-Nov-19, 3.57 For personal use only $3.00 $2.00 $1.00 $0.00 Source: https://www.investing.com/equities/integral-diagnostics-ltd-historical-data 12
Slide 14: Industry is growing at 7.2%, driven by high value modalities
Industry is growing at 7.2%, driven by increasing use of high value, high margin modalities (CT, MRI and Nuclear Medicine) For personal use only Source: Medicare Australia Statistics for the states where IDX operates 13
Slide 15: Industry leadership
Industry leadership IDX plays an active role in ensuring that ANZ Diagnostic Imaging services retain their pre-eminent position and reputation for high quality care, services, training and research. For personal use only IDX is the annual sponsor of the graduation ceremony for new RANZCR graduates
Slide 16: Developing the Industry: Australia lags in MRI utilisation
Developing the Industry: Australia lags the developed world with regard to MRI utilisation MRI Scans Per 1,000 Population* For personal use only 90 80 70 60 50 40 30 20 10 0 2012 2013 2014 2015 2016 2017 **2018 MRI Average OECD MRI Australia Australian patients are not receiving the benefits of a te
Slide 17: Corporate social responsibility
Corporate social responsibility IDX actively drives social programs that assist patients in need to access vital diagnostic imaging services For personal use only Radiology Across Borders Strategic partnership with Radiology Across Borders (RAB) to provide radiology development and training opportun
Slide 18: IDX Priorities for 2020
For personal use only IDX Priorities for 2020 Confidential / Draft 17
Slide 19: FY20 priorities
FY20 priorities… DI is at the intersection of health and technology For personal use only Capitalise on new diagnostic technologies • Commission new digital PET scanner at John Flynn Private Hospital on the Gold Coast • Installed Cardiac CTs at SJOG Hospitals in Geelong and Mandurah and at Ramsay’s
Slide 20: FY20 priorities continued
FY20 priorities continued Promote our values, integrate our acquisitions, and develop the industry For personal use only Invest in recruitment and retention of world leading radiologist and clinical staff • Implement recruitment strategies that attract ANZ’s premier radiologists • Promote the IDX Va
Slide 21: Questions?
For personal use only Questions? 20
Slide 22: Disclaimer
Disclaimer Some of the information contained in this presentation contains “forward-looking statements” which may not directly or exclusively relate to historical facts. These forward-looking statements reflect Integral Diagnostics Limited (IDX) current intentions, plans, expectations, assumptions a
Integral Diagnostics — Shareholder Meeting (November 2019) on 6ix